Trichostatin A-induced apoptosis is mediated by Kruppel-like factor 4 in ovarian and lung cancer

Sadeghi Zohre1, Nejati-Koshki Kazem, Akbarzadeh Abolfazl

  • 1Hematology and Oncology Research Center, Tabriz, Iran

Abstract

Insights

Trichostatin A (TSA) increases Kruppel-like factor 4 (klf4) expression, inhibiting cancer cell growth and promoting apoptosis in ovarian and lung cancer cells. This suggests klf4 acts as a tumor suppressor in response to HDAC inhibition.

Area of Science:

  • Cancer Biology
  • Molecular Oncology
  • Epigenetics

Background:

  • Histone deacetylase (HDAC) inhibitors like trichostatin A (TSA) regulate gene expression and inhibit cancer cell proliferation.
  • Kruppel-like factor 4 (klf4) is a transcription factor involved in cell proliferation, differentiation, tumorigenesis, and apoptosis, with context-dependent roles in cancer.

Purpose of the Study:

  • To investigate if TSA upregulates klf4 expression and induces growth inhibition and apoptosis in SKOV-3 (ovarian) and A549 (lung) cancer cell lines.
  • To explore the molecular mechanisms underlying HDAC inhibitor-induced effects on cancer cells.

Main Methods:

  • Cytotoxicity assessed using MTT assay.
  • klf4 gene expression analyzed by real-time PCR.
  • Apoptosis induction evaluated via Vybrant Apoptosis Assay kit and flow cytometry.

Main Results:

  • TSA demonstrated dose- and time-dependent cytotoxicity against SKOV-3 and A549 cells.
  • TSA treatment led to increased klf4 expression.
  • Flow cytometry confirmed elevated apoptosis levels post-TSA treatment.

Conclusions:

  • TSA upregulates klf4 expression in SKOV-3 and A549 cells, suggesting klf4 plays a tumor-suppressive role.
  • Increased klf4 expression contributes to TSA-mediated cell growth inhibition and apoptosis.
  • This study elucidates molecular mechanisms of HDAC inhibitor action, including cell cycle arrest and apoptosis induction.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K